Xenon Pharmaceuticals Inc. (FRA:XP0)

Germany flag Germany · Delayed Price · Currency is EUR
38.00
+0.20 (0.53%)
At close: Dec 5, 2025
-5.00%
Market Cap 2.96B
Revenue (ttm) 6.39M
Net Income (ttm) -261.09M
Shares Out n/a
EPS (ttm) -3.31
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume 8
Open 38.00
Previous Close 37.80
Day's Range 38.00 - 38.00
52-Week Range 25.00 - 40.60
Beta n/a
RSI 61.78
Earnings Date Feb 27, 2026

About Xenon Pharmaceuticals

Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company, engages in the discovery, development, and delivery of therapeutics to treat patients with neurological and psychiatric disorders in Canada. Its product candidates include Azetukalner, a selective Kv7 potassium channel opener in Phase 3 clinical development for the treatment of epilepsy, including focal onset seizures, and primary generalized tonic-clonic seizures, as well as neuropsychiatric disorders, such as major depressive disorder and bipolar depression. The com... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1996
Employees 327
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol XP0
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.